Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal oxytocin, 5-HT1B receptor PET, and social behavior in healthy men
jRCTs041240017Recruiting
- Start
- Jul 2024
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Randomised, double-blind trial of oxytocin (2 arms). Primary endpoint: Serotonin 1B receptor binding potential. Started Jul 2024; status: recruiting.
02
Drugs
oxytocin
Beyond the preview
Go deeper on jRCTs041240017.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs041240017.